[go: up one dir, main page]

NO20006381L - Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler - Google Patents

Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler

Info

Publication number
NO20006381L
NO20006381L NO20006381A NO20006381A NO20006381L NO 20006381 L NO20006381 L NO 20006381L NO 20006381 A NO20006381 A NO 20006381A NO 20006381 A NO20006381 A NO 20006381A NO 20006381 L NO20006381 L NO 20006381L
Authority
NO
Norway
Prior art keywords
compositions
serm
selective
growth hormone
estrogen receptor
Prior art date
Application number
NO20006381A
Other languages
English (en)
Other versions
NO20006381D0 (no
Inventor
Hua Zhu Ke
Mei Li
Lydia Codetta Pan
David Duane Thompson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20006381D0 publication Critical patent/NO20006381D0/no
Publication of NO20006381L publication Critical patent/NO20006381L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det er beskrevet farmasøytiske kombinasjonssammensetninger og fremgangsmåter omfattende (-)-cis-6-fenyl-5-(4-(2-pyrrolidin-1 -yl-etoksy)-fenyl)-S.ej.S-tetrahydronaftalen^-ol eller et farmasøytiskakseptabelt salt derav og 2-amino-N-(1(RH2,4-difluor-benzyloksymetyl)-2okso-2-(3-okso-3a(R)-pyirdin-2-yl-metyl^^^^-tnfluortyl^.a.aa^.ej-heksahydro-pyrazol^^cjpyridin-S-yl)-etyl)-2-metyl-propionamid eller et farmasøytisk akseptabelt salt derav, fremgangsmåter for anvendelse.av slike sammensetninger og settinneholdende slike. sammensetninger. Sammensetningene er nyttige for behandling av muskel-skjelettsvakhet, inkludert osteoporose, osteoporotiske brudd, lav benmasse, skjørhet og lav muskelmasse.
NO20006381A 1998-06-16 2000-12-14 Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler NO20006381L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8942498P 1998-06-16 1998-06-16
PCT/IB1999/000796 WO1999065488A1 (en) 1998-06-16 1999-05-03 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (2)

Publication Number Publication Date
NO20006381D0 NO20006381D0 (no) 2000-12-14
NO20006381L true NO20006381L (no) 2000-12-14

Family

ID=22217565

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006381A NO20006381L (no) 1998-06-16 2000-12-14 Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler

Country Status (29)

Country Link
EP (1) EP1085867A1 (no)
JP (1) JP2002518328A (no)
KR (1) KR20010052817A (no)
CN (1) CN1305378A (no)
AP (1) AP9901581A0 (no)
AR (1) AR018868A1 (no)
AU (1) AU3342099A (no)
BG (1) BG105128A (no)
BR (1) BR9911357A (no)
CA (1) CA2335112A1 (no)
CO (1) CO5070586A1 (no)
EA (1) EA200001189A1 (no)
GT (1) GT199900083A (no)
HR (1) HRP20000857A2 (no)
HU (1) HUP0102395A2 (no)
ID (1) ID26726A (no)
IL (1) IL139587A0 (no)
IS (1) IS5727A (no)
MA (1) MA26648A1 (no)
NO (1) NO20006381L (no)
OA (1) OA11569A (no)
PA (1) PA8472101A1 (no)
PE (1) PE20000633A1 (no)
PL (1) PL345064A1 (no)
SK (1) SK18902000A3 (no)
TN (1) TNSN99118A1 (no)
UY (1) UY25557A1 (no)
WO (1) WO1999065488A1 (no)
ZA (1) ZA993973B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004306A3 (en) * 1998-08-06 2000-06-07 Pfizer Products Inc. Estrogen agonists/antagonists
CA2420535A1 (en) * 2000-08-30 2002-03-07 Mary Tanya Am Ende Sustained release formulations for growth hormone secretagogues
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
US7524866B2 (en) 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
SI1460969T1 (sl) * 2001-11-29 2008-10-31 Gtx Inc Preprečevanje in zdravljenje s pomanjkanjem androgena inducirane osteoporoze
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
ES2602789T3 (es) 2007-02-09 2017-02-22 Ocera Therapeutics, Inc. Productos intermedios conectores para la síntesis de moduladores macrocíclicos del receptor de la grelina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
HUP0102395A2 (hu) 2001-11-28
PA8472101A1 (es) 2000-09-29
BG105128A (en) 2001-11-30
KR20010052817A (ko) 2001-06-25
IL139587A0 (en) 2002-02-10
MA26648A1 (fr) 2004-12-20
CA2335112A1 (en) 1999-12-23
EA200001189A1 (ru) 2001-06-25
NO20006381D0 (no) 2000-12-14
HRP20000857A2 (en) 2001-10-31
BR9911357A (pt) 2001-03-13
EP1085867A1 (en) 2001-03-28
AU3342099A (en) 2000-01-05
SK18902000A3 (sk) 2001-12-03
IS5727A (is) 2000-11-24
AR018868A1 (es) 2001-12-12
ID26726A (id) 2001-02-01
WO1999065488A1 (en) 1999-12-23
OA11569A (en) 2004-07-01
CN1305378A (zh) 2001-07-25
TNSN99118A1 (fr) 2005-11-10
PL345064A1 (en) 2001-11-19
PE20000633A1 (es) 2000-07-26
CO5070586A1 (es) 2001-08-28
UY25557A1 (es) 2001-01-31
JP2002518328A (ja) 2002-06-25
AP9901581A0 (en) 1999-06-30
GT199900083A (es) 2000-12-05
ZA993973B (en) 2000-12-15

Similar Documents

Publication Publication Date Title
SI1389963T1 (sl) Kostna ploscica za fiksiranje zlomov proksimalnega humerusa
YU18400A (sh) Prostaglanidin agonisti i njihova primena za tretiranje koštanih poremećaja
AU651369B2 (en) Method and apparatus for the fixation of bone fractures, limb lengthening and the correction of deformities
EP1236475A3 (en) Combination therapy for osteoporosis consisting of an estrogen agonist/antagonist and a growth hormone secretagogue
HK1077998A1 (en) Apparatuses for therapeutically treating damaged tissues, bone fractures, osteopenia, or osteoporosis
NO951498L (no) Farmasöytisk preparat for behandling av osteoporose
NO20006381L (no) Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler
DK0937478T3 (da) Indretning og apparat til intrakavitær indgivelse af lægemidler under videounderstøttet kirurgi eller anden endoskopisk fremgangsmåde
WO2001043733A3 (en) Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
BG105125A (en) Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
ID18079A (id) Komposisi farmasi yang mengandung bahan pemercepat osteogenesis
DK1420827T3 (da) 5-CNAC sp, oralt indgivelsesmiddel for parathyroidhormonfragmenter
NO20006312L (no) Terapeutiske blandinger av selektive östrogenreseptor- modulatorer (SERM) og veksthormon sekretstimulerende middel (GHS) for behandling av muskuloskjelett skjörhet
UA26204C2 (uk) Спосіб запобігаhhя деградації кісткового протеза
PT966968E (pt) Combinacoes terapeuticas compreendendo um modulador de receptor de estrogenio selectivo e prostaglandina e2
ECSP993021A (es) Combinaciones terapeuticas para la fragilidad musculoesqueletica
WO2001032191A3 (en) Phytoestrogenic pharmaceutical preparations
ECSP993016A (es) Combinaciones terapeuticas que comprenden un modulador del receptor de estrogenos selectivo y hormona paratoroidea
ECSP993020A (es) Terapia de combinacion para la fragilidad musculoesqueletica
AU2001265248A1 (en) Measurement of the therapeutic dose for bone marrow ablation therapy
TH57984A3 (th) การรวมในทางการรักษาซี่งประกอบด้วยตัวปรับตัวรับเอสโตรเจนแบบคัดเลือกและฮอร์โมนพาราไธรอยด์
RU2003125500A (ru) Способ лечения переломов проксимального отдела бедренной кости с отрывом малого вертела при коксартрозе
TH48282A (th) การรักษาโรคของการให้ยาประกอบร่วมกันของโรคกระดูกพรุน
UA28851A (uk) Спосіб оперативного лікування переломів дистального метаепіфізу великогомілкової кістки

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application